Exercise capacity and ventilatory response during exercise in COPD patients with and without β blockade
- PMID: 23877368
- DOI: 10.1007/s00408-013-9492-2
Exercise capacity and ventilatory response during exercise in COPD patients with and without β blockade
Abstract
Background: Although β blockade (BB) in patients with chronic obstructive pulmonary disease (COPD) does not show signs of worsening pulmonary function or respiratory symptoms, the effects on cardiopulmonary exercise testing (CPET) remain unclear. The aim of this study was to determine whether BB affects exercise capacity, gas exchange, and hemodynamic responses in patients with COPD.
Methods: Twenty-four COPD subjects on BB were matched to 24 COPD subjects without BB according to age, gender, body mass index, and severity of COPD. All subjects underwent resting pulmonary function and symptom-limited CPET.
Results: Comparing COPD patients with and without BB revealed that percent peak oxygen consumption and VE/VCO2 nadir were not significantly different (45 ± 16 vs. 51 ± 23 %, p = 0.30, and 35.1 ± 8.5 vs. 36.2 ± 11.6 %, p = 0.69). Systolic blood pressure and heart rate at peak exercise were significantly decreased in COPD patients with BB (168 ± 16 vs. 185 ± 20 mmHg, and 109 ± 16 vs. 122 ± 14 bpm, respectively, p < 0.05).
Conclusion: Exercise capacity and gas exchange remain unaffected in patients with COPD in the presence of BB, although heart rate and blood pressure are lower. These findings imply that BB does not adversely affect functional capacity in patients with COPD.
Similar articles
-
Comparison of cardiopulmonary exercise testing variables in COPD patients with and without coronary artery disease.Heart Lung. 2014 Mar-Apr;43(2):146-51. doi: 10.1016/j.hrtlng.2013.12.005. Heart Lung. 2014. PMID: 24594250
-
Effects of sildenafil on gas exchange, ventilatory, and sensory responses to exercise in subjects with mild-to-moderate COPD: A randomized cross-over trial.Respir Physiol Neurobiol. 2025 Jan;331:104359. doi: 10.1016/j.resp.2024.104359. Epub 2024 Oct 9. Respir Physiol Neurobiol. 2025. PMID: 39389522 Clinical Trial.
-
Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure.Int J Cardiol. 2015;189:134-40. doi: 10.1016/j.ijcard.2015.03.422. Epub 2015 Mar 31. Int J Cardiol. 2015. PMID: 25889444
-
Effect of exercise training on ventilatory efficiency in patients with heart disease: a review.Braz J Med Biol Res. 2016 Jun 20;49(7):e5180. doi: 10.1590/1414-431X20165180. Braz J Med Biol Res. 2016. PMID: 27332771 Free PMC article. Review.
-
Pulmonary gas exchange and ventilatory efficiency during exercise in health and diseases.Expert Rev Respir Med. 2024 Jun;18(6):355-367. doi: 10.1080/17476348.2024.2370447. Epub 2024 Jun 27. Expert Rev Respir Med. 2024. PMID: 38912849 Review.
Cited by
-
Impact of bisoprolol and amlodipine on cardiopulmonary responses and symptoms during exercise in patients with chronic obstructive pulmonary disease.PLoS One. 2023 Jun 1;18(6):e0286302. doi: 10.1371/journal.pone.0286302. eCollection 2023. PLoS One. 2023. PMID: 37262049 Free PMC article.
-
Exertional ventilation/carbon dioxide output relationship in COPD: from physiological mechanisms to clinical applications.Eur Respir Rev. 2021 Sep 15;30(161):200190. doi: 10.1183/16000617.0190-2020. Print 2021 Sep 30. Eur Respir Rev. 2021. PMID: 34526312 Free PMC article. Review.
-
Increasing exercise capacity and physical activity in the COPD patient.Breathe (Sheff). 2024 Jun 11;20(2):230347. doi: 10.1183/20734735.0347-2023. eCollection 2024 Jun. Breathe (Sheff). 2024. PMID: 38873235 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical